Evidence map›Paper›PMID 42291306›Full record

ArticleFrontiers in cellular and infection microbiology2026

Harnessing interpretable deep learning to predict resistance in

Nicolas da Matta Freire Araujo, Márcia da Silva Chagas, Mateus Fernandes Santos, Renata Freire Alves Pereira, Rafaela Correia Brum, Felipe Ramos Pinheiro, Melise Chaves Silveira, Felicita Mabel Duré, Beatriz de Lima Alessio Müller, Audrien Alves Andrade de Souza and 10 more

Abstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Nicolas da Matta Freire AraujoScientific Computing Program, Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil.
Márcia da Silva ChagasScientific Computing Program, Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil.
Mateus Fernandes SantosDepartment of Applied Mathematics, Institute of Mathematics, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil.
Renata Freire Alves PereiraLaboratory of Molecular Epidemiology and Biotechnology, School of Pharmacy/Fluminense Federal University, Niteroi, RJ, Brazil.
Rafaela Correia BrumDepartment of System Engineering and Computation, State University of Rio de Janeiro, Rio de Janeiro, Brazil.
Felipe Ramos PinheiroLaboratory of Molecular Epidemiology and Biotechnology, School of Pharmacy/Fluminense Federal University, Niteroi, RJ, Brazil.
Melise Chaves SilveiraBioinformatics Laboratory, National Laboratory for Scientific Computing (LNCC/MCTI), Petrópolis, Brazil.
Felicita Mabel DuréScientific Computing Program, Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil.
Beatriz de Lima Alessio MüllerLaboratory of Applied Genomics and Bioinnovations - Oswaldo Cruz Foundation / Instituto Oswaldo Cruz (IOC/FIOCRUZ), Next-Generation Sequencing Platforms (IOC/RPT01J) - Network of Technological Platforms/FIOCRUZ, Rio de Janeiro, Brazil.
Audrien Alves Andrade de SouzaLaboratory of Applied Genomics and Bioinnovations - Oswaldo Cruz Foundation / Instituto Oswaldo Cruz (IOC/FIOCRUZ), Next-Generation Sequencing Platforms (IOC/RPT01J) - Network of Technological Platforms/FIOCRUZ, Rio de Janeiro, Brazil.
Alessandra Beatriz Santos Rondon SouzaGraduate Program in Applied Microbiology and Parasitology. Biomedical Institute - Fluminense Federal University, Niteroi, RJ, Brazil.
Ágatha Ferreira de SouzaLaboratory of Gram-Positive Cocci/Fluminense Federal University, Niteroi, RJ, Brazil.
Ana Paula D'Alincourt Carvalho-AssefLaboratory of Bacteriology Applied to One Health and Antimicrobial Resistance, Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil.
Aline Dos Santos MoreiraLaboratory of Applied Genomics and Bioinnovations - Oswaldo Cruz Foundation / Instituto Oswaldo Cruz (IOC/FIOCRUZ), Next-Generation Sequencing Platforms (IOC/RPT01J) - Network of Technological Platforms/FIOCRUZ, Rio de Janeiro, Brazil.
Marcelo Trindade Dos SantosDepartment of Computational Modeling, National Laboratory for Scientific Computing (LNCC/MCTI), Petrópolis, Brazil.
Adriano Maurício de Almeida CôrtesDepartment of Applied Mathematics, Institute of Mathematics, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil.
Bruno de Araújo PennaGraduate Program in Applied Microbiology and Parasitology. Biomedical Institute - Fluminense Federal University, Niteroi, RJ, Brazil.
Thiago Pavoni Gomes ChagasLaboratory of Molecular Epidemiology and Biotechnology, School of Pharmacy/Fluminense Federal University, Niteroi, RJ, Brazil.
Fábio Aguiar-AlvesLaboratory of Molecular Epidemiology and Biotechnology, School of Pharmacy/Fluminense Federal University, Niteroi, RJ, Brazil.
Fabrício Alves Barbosa da SilvaScientific Computing Program, Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Antimicrobial resistance poses a growing global health threat, complicating therapeutic management and increasing morbidity and mortality. Deep learning methods have emerged as effective tools for bacterial profiling using omics data, particularly in predicting antimicrobial susceptibility from genomic information. The present study focuses on identifying genomic signatures linked to resistance mechanisms using a deep learning architecture. Methods: DeepMDC, a deep learning architecture for bacterial profiling using whole-genome data, is introduced. Due to the high cost and ambiguity of precise gene- or mutation-level annotation, phenotypic classification is formulated as a Multiple Instance Learning (MIL) problem, in which each genome is represented as a bag of instances with a single associated label. The architecture centers on a modern Hopfield network that processes all open reading frames (ORFs), including small ORFs, derived from genomic data. Interpretability is achieved through attention mechanisms, which facilitate biological insight and support hypothesis generation. Results: The model was evaluated against Discussion: Notably, genes associated with resistance consistently received high attention scores during inference, validating the architecture and potentially generating new hypotheses.

Indexed as

Anti-Bacterial AgentsDeep LearningDrug Resistance, BacterialKlebsiella pneumoniaeDrug Resistance, Multiple, BacterialGenome, BacterialGenomicsHumansKlebsiella InfectionsMicrobial Sensitivity TestsOpen Reading FramesAnti-Bacterial Agentsantimicrobial resistancedeep learninggenomicsKlebsiella pneumoniaemodern Hopfield networks

Identifiers

PMID42291306
PMCPMC13253382

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.